Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 11,221–11,240 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

ULTRA-TEST in Grapeseed Oil (CYP 90%/PROP 10%) Injectable, 200 mg/mL, 8 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Nicotinamide Adenine Dinucleotide (NADH) - Lyophilized (P.F.) 100 mg Injectable, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

MIC Combo - Standard 15 mg/50 mg/100 mg/mL Injectable, 30 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine HCl Injectable, 1 mg/mL (0.1%), 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

QUAD3 (PAP/PHEN/ALPRO/ATRO) 30 mg/3 mg/30 mcg/0.1mL Injectable, a) 2 mL and 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Enanthate in Grapeseed Oil Injectable, 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate in Grapeseed Oil Injectable, 200 mg/mL, a) 1 mL b) 3 mL c) 5 mL and d) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21

by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals

Reason
Failed Stability Specifications
Recall initiated
December 22, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Vitamin D3 100,000 Unit/mL, in olive oil, (30 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Ultra Slim Shot (Methionine (L) 25mg/Inositol 50mg/Choline Chloride 50 mg/Methylcobalamin 1mg/Carnitine (L) 170mg/Pyridoxine HCL 2mg/Lidocaine HCL 10mg/mL), (30 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Ultra Cocktail #2 (Methionine (L) 12.5mg/Inositol 25mg/Choline Chloride 25 mg/Methylcobalamin 300mcg/Carnitine (L) 170mg/Thiamine HCL 20mg/Riboflavin-5-Phosphate Sod 2mg/Pyridoxine HCL 2mg/Folic Acid 2mg/Ascorbic Acid 20mg/Chromium Picolinate 66mcg/Lidocaine HCL 10mg/mL), (30 ML and 10 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Ultra Amino Energy Cocktail (Methionine (L) 12.5mg/Inositol 25mg/Choline Chloride 25 mg/Methylcobalamin 300mcg/Carnitine (L) 125mg/Thiamine HCL 50mg/Riboflavin-5-Phosphate Sod 5mg/Miacinamide 20mg/Pyridoxine HCL 2mg/Folic Acid 2mg/Ascorbic Acid 50mg/Chromium Picolinate 200mcg/Glutamine (L) 30mg/Arginine HCL 200mg/Lidocaine HCL 10mg/mL), (30 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 100mcg/3mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 40mcg/2mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 30mcg/1mg/10mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 30mcg/0.5mg/10mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 30mcg/1mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 20mcg/0.5mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 20mcg/2mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.